Page last updated: 2024-08-23

idarubicin and Mast-Cell Leukemia

idarubicin has been researched along with Mast-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen-Liang, TH; Florensa, L; Jerez, A; Ortuño, FJ	1

Other Studies

1 other study(ies) available for idarubicin and Mast-Cell Leukemia

Article	Year
[Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia]. Medicina clinica, 2015, Jun-22, Volume: 144, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunophenotyping; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Mast Cells; Mutation; Neoplasm Proteins; Neoplastic Stem Cells; Prognosis; Vidarabine	2015

Article

Year

[Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].

Medicina clinica, 2015, Jun-22, Volume: 144, Issue:12

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Drug Resistance, Neoplasm; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunophenotyping; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Mast Cells; Mutation; Neoplasm Proteins; Neoplastic Stem Cells; Prognosis; Vidarabine

2015